The US and Canada have healthcare, life science and medical device industries that are complex and interconnected.
On March 6, President Donald Trump instituted a 25 percent ad valorem rate of duty on goods imported from Canada under the International Emergency Economic Powers Act.[1] The tariffs will not be implemented on goods that comply with the United States-MexicoCanada Agreement until April 2.[2] In turn, Canada has announced a $155 billion tariff package on the US.[3]
Download the full Law360 article, "Mitigating Tariff Risks For Healthcare In US And Canada."
Publication
Two recent judgments – decided just days apart – from different judges of the Northern District of California District Court determined that using copyrighted books to train large language models (LLMs) was fair use.
Publication
Recent announcements by the Canadian federal government to invest billions of dollars to modernize the Canadian Armed Forces, build a self-sufficient domestic defence and security industrial base, and reduce reliance on the United States for defence capabilities signal Canada’s renewed commitment to national defence and security and a diversification of its strategic alliances.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025
